Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-09-001330
Filing Date
2009-10-02
Accepted
2009-10-02 14:14:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 amylin13g10209.htm SC 13G 45484
  Complete submission text file 0000935836-09-001330.txt   47456
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Subject) CIK: 0000881464 (see all company filings)

EIN.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42168 | Film No.: 091101671
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MARKET PLAZA STEUART TOWER, 22ND FLOOR SAN FRANCISCO CA 94105
Business Address ONE MARKET PLAZA STEUART TOWER, 22ND FLOOR SAN FRANCISCO CA 94105 415-281-1022
Partner Fund Management, L.P. (Filed by) CIK: 0001442756 (see all company filings)

EIN.: 262000428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G